Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome
about
Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy backgroundSex differences in Sjögren's syndrome: a comprehensive review of immune mechanismsThe clinical relevance of animal models in Sjögren's syndrome: the interferon signature from mouse to manPlasmacytoid dendritic cells of the gut: relevance to immunity and pathologyInterferons in Sjögren's Syndrome: Genes, Mechanisms, and EffectsThe plasmacytoid dendritic cell as the Swiss army knife of the immune system: molecular regulation of its multifaceted functionsTargeting dendritic cell function during systemic autoimmunity to restore toleranceIdentification of potential genomic biomarkers for Sjögren's syndrome using data pooling of gene expression microarraysType I interferon signature is high in lupus and neuromyelitis optica but low in multiple sclerosisA type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosisSalivary gland hypofunction induced by activation of innate immunity is dependent on type I interferon signaling.Activation of innate immune responses through Toll-like receptor 3 causes a rapid loss of salivary gland functionText-mining applied to autoimmune disease research: the Sjögren's syndrome knowledge base.BDCA2/Fc epsilon RI gamma complex signals through a novel BCR-like pathway in human plasmacytoid dendritic cellsTolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome.Safety, Tolerability, and Immunogenicity of InterferonsGenome-wide DNA methylation patterns in naive CD4+ T cells from patients with primary Sjögren's syndrome.Genome-wide association studies in Sjögren's syndrome: What do the genes tell us about disease pathogenesis?Association of endogenous anti-interferon-α autoantibodies with decreased interferon-pathway and disease activity in patients with systemic lupus erythematosus.MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosisCutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis.Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome.Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.Effect of soluble ICAM-1 on a Sjögren's syndrome-like phenotype in NOD mice is disease stage dependent.Pivotal Functions of Plasmacytoid Dendritic Cells in Systemic Autoimmune Pathogenesis.Hepatitis Delta Virus Detected in Salivary Glands of Sjögren's Syndrome Patients and Recapitulates a Sjögren's Syndrome-Like Phenotype in Vivo.Association of EBF1, FAM167A(C8orf13)-BLK and TNFSF4 gene variants with primary Sjögren's syndrome.NETs: the missing link between cell death and systemic autoimmune diseases?Genes and Sjögren's syndrome.NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome.Dendritic cell subsets in health and disease.Cytokines in Sjogren's syndrome: potential therapeutic targets.Dry eye as a mucosal autoimmune disease.Altered phenotype and Stat1 expression in Toll-like receptor 7/8 stimulated monocyte-derived dendritic cells from patients with primary Sjögren's syndrome.No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndromeB cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndromeGenetics and genomics of Sjögren's syndrome: research provides clues to pathogenesis and novel therapies.Dysfunction of lacrimal and salivary glands in Sjögren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model.
P2860
Q24273412-F60C8B8A-2C86-46D8-BBDA-5BD5F8D7CEC1Q26780324-61B9D2E7-BA2B-4B68-A6D1-8C44D8788B2BQ26825196-791607AC-9714-4DF4-9518-760F78BF0659Q26864144-D51F3344-4F09-48E2-81AC-4B26C3166DC6Q26865427-1FFEC229-5115-4D69-82D5-2D6625895A30Q27023380-1CADDA16-81C5-46DB-9964-3CF8DB58CB93Q27687098-B68E866D-03F1-42B9-AA1B-8A7F683E0F09Q28249978-5737869D-961F-45F2-9479-DDC36FE297E0Q28251763-9DC4A4B8-193C-4053-9DC2-6B1BCBC66CCEQ28257957-83D02F11-4966-400C-BAB5-C4B63832BAA6Q30415532-3C18A763-893C-4EFE-9330-343C7E256414Q30437519-EA81B960-A95D-4551-9C44-20889BEF603FQ31070967-4EC695A9-BDC3-4A4E-99AC-0B695DE47ED4Q33298653-F4778E54-0ABC-47B9-82F7-B49970B41620Q33372523-D641AAAD-F181-44B4-A838-3D34DF988A7BQ33435810-285FA3E6-9825-43EB-887A-69525B1BEDD7Q33565851-8FBC6840-58C4-4D1C-9511-B6393C564BEFQ33601647-F413AEAA-267A-4808-8AEF-C51A9C979556Q33637845-91511708-C844-4797-8BEA-348DF287A21FQ33659118-9492F26B-5558-4374-8567-1C5BAAFB46CFQ33693955-3D5FA524-E185-44B5-A65A-06786DDBEC9DQ33756218-38C09559-7ED1-416C-B10D-3B07B57072DBQ33766714-3649CB68-66BC-4449-AF26-509CCA7F9E98Q33798937-615F65B0-C96D-435C-8652-97E187450621Q33884499-143050E0-46B5-4E42-B6CE-711893F08CC2Q33903979-08EA6C1F-05AD-44AC-BCCF-0EF695C6C618Q33956662-617BE516-085B-403A-8C59-BF95BDAF07FCQ34047019-3924CA40-0C2E-4491-8AE0-BCB6F369F897Q34139580-2A0CAE23-4E13-4C41-B62C-0DB6C6DA13C3Q34323566-2EEC6569-F11A-447B-B0DB-DF746F8EC986Q34363380-30977168-B9F9-46BA-BC04-F156E65E34BBQ34541173-F12B2C4C-7DD8-440D-B489-F61B2E1ABE59Q34582889-3E4E71AF-EF27-45B3-B90D-983D7DE609ECQ34601660-17BCC7D8-68AA-4E2B-B5F3-C1D11EF72DEFQ34647761-C00792D3-6964-485F-B0AE-5A509FC8DD23Q34669630-9CB56FD1-9527-4E4B-B33E-A11C64A51586Q34896464-670E7623-934D-495E-A1E0-FF214BF73F8AQ34896699-22064D74-7954-43F4-9F42-9F9083863989Q34984739-F57A1E54-0F0D-4C8D-A8B4-688ACCE52C56Q35031736-B9975177-969E-41BD-BBC2-D0316A5DF157
P2860
Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@ast
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@en
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@nl
type
label
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@ast
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@en
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@nl
prefLabel
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@ast
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@en
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@nl
P2093
P2860
P356
P1476
Activation of IFN pathways and ...... of primary Sjögren's syndrome
@en
P2093
Carlo Lucchesi
Catherine Fournier
Christine Lepajolec
Franck Letourneur
Gilles Chiocchia
Jean Sibilia
Marc Ardizzone
Marc Ittah
Marc Labetoulle
Nathalie Ba
P2860
P304
P356
10.1073/PNAS.0510837103
P407
P577
2006-02-13T00:00:00Z